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Cytosolic hybrid histidine kinases (HHKs) constitute major signaling
nodes that control various biological processes, but their input
signals and how these are processed are largely unknown. In
Caulobacter crescentus, the HHK ShkA is essential for accurate timing
of the G1-S cell cycle transition and is regulated by the corresponding
increase in the level of the secondmessenger c-di-GMP. Here, we use
a combination of X-ray crystallography, NMR spectroscopy, func-
tional analyses, and kinetic modeling to reveal the regulatory mech-
anism of ShkA. In the absence of c-di-GMP, ShkA predominantly
adopts a compact domain arrangement that is catalytically inactive.
C-di-GMP binds to the dedicated pseudoreceiver domain Rec1,
thereby liberating the canonical Rec2 domain from its central posi-
tion where it obstructs the large-scale motions required for catalysis.
Thus, c-di-GMP cannot only stabilize domain interactions, but also
engage in domain dissociation to allosterically invoke a downstream
effect. Enzyme kinetics data are consistent with conformational se-
lection of the ensemble of active domain constellations by the ligand
and show that autophosphorylation is a reversible process.
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Two-component systems (TCSs) are widespread in microor-ganisms and mediate signal-dependent regulation of gene ex-
pression. They link diverse intracellular and extracellular stimuli to
specific cellular responses, including development, cell division,
and antibiotic resistance (1, 2). In their simplest form, TCSs are
composed of a sensory histidine kinase (HK) and its cognate re-
sponse regulator (for recent review, see refs. 3 and 4). The sensory
HK is usually a homodimer that autophosphorylates a histidine in
response to an input signal and then catalyzes transfer of the
phosphoryl group to a conserved aspartate on the receiver domain
(Rec) of its partner response regulator, thereby modifying its ac-
tivity. As well as a Rec domain, response regulators usually harbor
an output effector domain that often functions as a transcription
factor. The HK catalytic core is composed of a dimerization and
histidine transfer (DHp) domain for carrying the active histidine,
and a catalytic ATP binding (CA) domain. The DHp domain
contains 2 α-helices that mediate homodimerization by forming
a 4-helix bundle. An exposed histidine residue in the DHp domain
is autophosphorylated by the CA domain, which forms an
α/β-sandwich that binds ATP. Phosphorelays, also called multi-
component systems, are more complex in that they include a his-
tidine phosphotransferase (Hpt) domain to enable phosphate
transfer between 2 Rec domains. In hybrid HKs (HHK) that
function as part of phosphorelays, the first Rec domain is fused C
terminally to the HK core. Although HHKs comprise almost 20%
of bacterial HKs (5), no detailed structural or mechanistic studies
on their regulation are available, apart from studies on the relaxed
specificity between the HK core and Rec (6, 7).
Typically, HKs perceive the signal by dedicated periplasmic
domains, but membrane spanning and cytosolic domains/proteins
are known to regulate them as well (8). Input domains, such as
PAS, GAF, and HAMP, are located N terminal to the HK
core and affect the conformation and dynamics of the dimeric
DHp helix bundle upon signal recognition, thereby controlling
autophosphorylation of the conserved histidine on the first DHp
α-helix (9–11) and initiating signal transduction. In contrast, ShkA,
investigated here, is a noncanonical HHK lacking any N-terminal
input domain, but exhibiting a pseudoreceiver domain (Rec1) be-
tween the kinase core and the C-terminal receiver domain (Fig. 1A).
It was suggested recently (12) that such a domain organization may
be common among HHKs and that the pseudoreceiver domain can
act as signal input domain by binding to small signaling molecules.
The second messenger, c-di-GMP, has been recognized as a
major player in bacterial signal transduction, regulating diverse
functions, including bacterial lifestyle, behavior, and development
(13). c-di-GMP is produced by diguanylate cyclases, and digua-
nylate cyclase domains (GGDEF), together with phosphodiester-
ase (EAL) domains (14), comprise the second-most common
group of TCS output domains, establishing a firm link between the
2 major systems in bacterial signaling. A connection in the oppo-
site direction has been discovered only recently in Caulobacter
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crescentus with the cell cycle HKCckA being controlled by c-di-GMP
(15). Increasing levels of c-di-GMP during the G1 phase cause
CckA to switch from default kinase to phosphatase mode upon
S-phase entry, thereby licensing cells for replication initiation.
Based on structural and functional analyses, c-di-GMP–mediated
cross-linking of the DHp and CA domain was proposed as the
molecular mechanism of the switch (16). Most recently, it was
found that ShkA, the other major kinase involved in the regulation
of the C. crescentus cell cycle progression and morphogenesis (17),
is also controlled by c-di-GMP (12). ShkA is a soluble HK that is
activated during the C. crescentus cell cycle by increasing levels of
the second messenger. Activation of ShkA initiates a multistep
phosphorylation cascade (Fig. 1A), consisting of the phospho-
transferase protein ShpA and the transcription factor TacA. Ac-
tivation of TacA by phosphorylation initiates a G1/S-specific
transcriptional program ultimately leading to cell morphogenesis
and S-phase entry (12, 17). Direct targets of TacA include spmX
and staR, encoding a critical morphogen and a transcriptional
regulator responsible for stalk elongation, respectively. In contrast
to CckA, which upon binding of c-di-GMP switches into phos-
phatase mode, the ligand is required for ShkA kinase activity,
suggesting a distinct mechanism of allosteric control.
Here, we reveal the molecular mechanism of ShkA regulation,
which is based on c-di-GMP–mediated mobilization of a locked,
autoinhibited domain arrangement. We have determined crystal
structures of full-length ShkA and of its isolated Rec1 domain in
complex with c-di-GMP and have analyzed the dynamics of the
full-length enzyme by NMR spectroscopy, employing isoleucine
methyl group isotope labeling. Comprehensive enzymatic anal-
yses revealed the underlying thermodynamics of the regulatory
mechanism. Finally, we propose a general model for the struc-
tural transitions during the catalytic cycle of HHKs.
Results
Full-Length ShkA Crystal Structure Reveals an Autoinhibited State of
ShkA. ShkA is a HHK composed of a DHp-CA core domain,
which catalyzes autophosphorylation of H23, and a Rec2 receiver
domain carrying the phospho-acceptor D430 (Fig. 1A). A second,
but degenerate, receiver domain Rec1 precedes Rec2. The crystal
structure of full-length ShkA was determined by molecular re-
placement to 2.65-Å resolution in the presence of AMPPNP/Mg2+
(SI Appendix, Table S1). The structure shows a crystallographic
dimer stabilized by contacts mediated by the DHp helices A1 and
A2 (Fig. 1B and SI Appendix, Fig. S1A). The DHp domain is
followed by a canonical CA domain with a tightly associated Rec1
domain (SI Appendix, Fig. S1B). Rec1 shows the canonical (βα)5
receiver domain fold (see also Fig. 3A), but with the fourth cross-
over helix degenerated to a loop (β3-β4 loop). The acidic pocket is
incomplete in that it has the 2 canonical acidic groups at the end of
β1 replaced by S255, P256, explaining why the domain is not in-
volved in phosphotransfer (17), despite the presence of an aspar-
tate (D297) in the canonical phospho-acceptor position (SI
Appendix, Fig. S2). Finally, the partly disordered Rec1-Rec2 linker
leads to the canonical Rec2 domain that is found associated with
the central DHp bundle (SI Appendix, Fig. S1C). Notably, the N-
terminal end of the Rec2 domain appears firmly tethered to Rec1
not through a direct contact, but via multiple ionic interactions
mediated mainly by a DDR motif on the Rec1-Rec2 linker (light
green in Fig. 1 B andC). Although the precise position of the Rec2
may depend on its crystal contact with a neighboring CA domain,
it is clear that dissociation of the DDR motif from the Rec1 do-
main would be required to allow autophosphorylation or phos-
photransfer. The structure of the AMPPNP/Mg2+ ligand bound to
the canonical CA site is well resolved, but 8 residues of the ATP lid
are unstructured (SI Appendix, Fig. S1 D and E).
The structure clearly represents an inactive, autoinhibited,
state of ShkA. Large conformational changes would be required
to allow access of bound ATP to H23 and of H23∼P to D430 for
autophosphorylation and phosphotransfer, respectively. Similarly,
DHp mediated dephosphorylation of D430∼P would require a
substantial rotation of Rec2 toward the putative hydrolytic water
thought to be bound to Thr27, 4 residues C terminal to the active
histidine as in CpxA (18) or HK853 (19).
C-di-GMP Binding Induces Large Conformational and Dynamic
Changes in ShkA. C-di-GMP binds to the Rec1 domain as shown
by NMR studies with the isolated domain (12). To investigate the
mechanism of c-di-GMP–mediated relief of the autoinhibited,
locked state (Fig. 1B), we next investigated the full-length enzyme
Rec2
Y338
R344
374
377
R324
Rec1
CA
I372
342
D370
R371
D369
a5
α5
β5
α4
b1
CARec1
Rec2
AMPPNP
DHp
DDR motif
Rec2’
Rec1’CA’
DHp’
Y338
R344
R324
Rec1-Rec2 linker
Mg2+
Rec1
CA
Rec1-Rec2 
linker Rec2
AMPPNP
D430
H23
H23’
D430’
14
DHp’DHp
496
90°
other
1 14 78 83 233 250 492 514
DHp
H2
3
Rec1 Rec2
D4
30
353 380
D3
69
D3
70
R3
71
CAATP
c-di-
GMP
Y3
38
ShpA TacA
DHp-CA-Rec1-DDR
Rec1
Rec2
ShkA
staR
spmX
DHp-CA-Rec1 (ΔRec2)
A
B
C
Fig. 1. Crystal structure of full-length ShkA dimer shows compact, auto-
inhibited domain arrangement. (A) ShkA domain organization with functional
residues indicated. The phospho-relay from ShkA via ShpA to transcription
factor TacA, which controls the expression of staR, spmX, and other genes
(broken arrows), is indicated by solid arrows. Constructs used in this study are
shown at the bottom (see also SI Appendix, Table S4). (B) Side and bottom view
of SkhA dimer in cartoon or surface representation with 1 protomer colored as
in A and the other (primed labels) in gray. Disordered loops are indicated by
dashed lines. His23, Asp430, and bound AMPPNP/Mg2+ are shown in CPK rep-
resentation. The structure represents an inactive, autoinhibited conformation,
since these potentially reacting groups are dispersed. For more structural details,
see SI Appendix, Fig. S1. (C) Detailed view of Rec1-Rec2 linker (red, with DDR
motif residues in light-green) bound to the α4-β5-α5 face of Rec1. Residues of
themotif interact with Rec1main-chain carbonyl 342 and R344 side-chain. Main-
chain carbonyls 374 and 377 of the linker interact with Rec1 R324, and I372
forms an apolar contact (with I327). Despite the absence of direct Rec1/Rec2
contacts, these interactions tether tightly the N terminus of Rec2 to Rec1.
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by NMR. A 2D [15N,1H]-TROSY spectra of uniformly deuterated
ShkA and ShkA/AMPPNP show only around 40 strong signals in
the random-coil region of the spectrum (Fig. 2A and SI Appendix,
Fig. S3A), indicating that they arise from residues located in locally
flexible regions of the protein. The large majority of the 489
nonproline residues of ShkA are, however, not detected in this
spectrum, due to the large molecular size of the rigid dimer and
the associated slow molecular tumbling.
Binding of AMPPNP to ShkA does not lead to major changes in
the spectrum. In contrast, binding of c-di-GMP to either apo ShkA
or ShkA/AMPPNP leads to dramatic spectral changes with around
120 well-resolved additional resonances being clearly detected,
indicating a substantial change in the dynamics of ShkA for a large
part of the protein (Fig. 2A and SI Appendix, Fig. S3A). This
massive increase in signal intensity is exemplified for selected
signals with their 1D 1H-cross sections (Fig. 2A and SI Appendix,
Fig. S3D). A spectral overlay of ShkA/c-di-GMP with the isolated
Rec2 domain shows that the new resonances perfectly overlap (SI
Appendix, Fig. S3A), including Rec2 residues that are in contact
with either the CA or DHp domain in the ShkA crystal structure
(A421, G422, R446, A447, K448, A471, A472, G473). This indi-
cates that upon binding of c-di-GMP to full-length ShkA, the Rec2
domain loses its contacts with the other domains and detaches
completely from the otherwise rigid main architecture of the
protein (SI Appendix, Fig. S3A). Since no significant chemical shift
differences are detected between the 2 spectra, the detached Rec2
domain in ShkA has essentially the same 3D structure as the
isolated Rec2 domain.
A
B C D
FE
Fig. 2. C-di-GMP binding to ShkA leads to release of the Rec2 domain. (A) Two-dimensional [15N,1H]-TROSY spectra of ShkA/AMPPNP (blue spectrum) and
ShkA/AMPPNP/c-di-GMP (red spectrum). The Insets show 1D [1H]-cross sections for representative amide protons. (B) Overlay of 2D [13C,1H]-HMQC spectra of
the isolated [13C/1Hδ1-Ile]Rec1 domain in apo state (blue) and c-di-GMP-bound state (red), and the isolated [13C/1Hδ1-Ile]Rec2 domain (purple). (C) Spectral
overlay of 2D [13C,1H]-HMQC spectra of [13C/1Hδ1-Ile]ShkA in apo state (blue) and c-di-GMP-bound state (red). The 2 Insets show 1D [1H]-cross sections for
representative methyl protons. Sequence-specific resonance assignments of the δ1 methyl groups are either indicated or assigned to the Rec2 or CA domain.
(D) Crystal structure of ShkA/AMPPNP. Surface representation of the monomer composed of 4 domains: DHp (dark gray), CA with bound AMPPNP (gray), Rec1
(light gray), and Rec2 (purple). The δ1 methyl groups of isoleucine residues in the Rec1 and Rec2 domains are shown as spheres together with I372 (red sphere)
that is part of the Rec1-Rec2 linker. (E) Chemical shift perturbation of isoleucine δ1 methyl groups upon addition of AMPPNP to ShkA (Upper) and upon
addition of c-di-GMP to ShkA/AMPPNP (Lower). (F) Transverse relaxation times of isoleucine δ1 methyl carbons of ShkA/AMPPNP (blue bars) and ShkA/
AMPPNP/c-di-GMP (red bars). The Lower panel shows the relative change of T2(
13C) upon addition of c-di-GMP (ΔT2). (E and F) Asterisks indicate methyl groups
that are either not assigned or line-broadened beyond detection in at least 1 of the 2 states.
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In order to obtain site-specific information of the effect of c-di-
GMP on the structure and dynamics of ShkA, we increased the
experimental sensitivity by employing methyl-NMR spectroscopy
of specifically δ1-[13C/1H]-isoleucine–labeled full-length ShkA and
isolated Rec1 and Rec2 domains (Fig. 2 B–D and SI Appendix, Fig.
S3B). Sequence-specific resonance assignments for Rec1 were
obtained by identifying unambiguous nuclear Overhauser effects
in agreement with the crystal structure. Additional assignments
for isoleucine methyl groups δ1-I340, δ1-I390, and δ1-I405 were
obtained using selective mutagenesis of full-length ShkA (SI
Appendix, Fig. S3C). The mutation I259V located within the
Rec1 domain caused major spectral changes, indicating the im-
portance of residue I259 in stabilizing the Rec1–CA domain in-
terface (SI Appendix, Fig. S1B).
AMPPNP binding to the CA domain of full-length ShkA leads
to only minimal chemical shift perturbation of the δ1-Ile methyl
groups of the entire protein, implying that the structures of
ligand-free and AMPPNP-bound ShkA are very similar (Fig. 2E
and SI Appendix, Fig. S3B). In contrast, binding of c-di-GMP to
either apo ShkA or to ShkA/AMPPNP causes substantial spec-
tral changes. All δ1-Ile methyl group signals of the Rec2 domain
strongly increase in intensity (SI Appendix, Fig. S3C), in full
agreement with the spectral behavior of the backbone amides.
Similar chemical shift changes were observed for c-di-GMP binding
either to the isolated ShkA-Rec1 domain or to full-length ShkA,
showing that c-di-GMP binds to the β5-α5 surface of prototypical
Rec domains (Fig. 2 C and E and SI Appendix, Fig. S3B).
Overall, these data indicate that c-di-GMP binding to ShkA
leads to liberation of the Rec2 domain from the protein core. To
validate this hypothesis, we conducted NMR spin relaxation
experiments in the presence and absence of c-di-GMP (Fig. 2F
and SI Appendix, Fig. S3F). For the isolated receiver domains,
average 13C transverse relaxation times for ILV methyl groups of
Rec2 and Rec1 are quite similar (174 ms and 160 ms, respectively),
in agreement with the similar molecular mass of both domains
(16.3 kDa and 12.5 kDa, respectively). For full-length ShkA/
AMPPNP in the absence of c-di-GMP, the transverse relaxation
times of all δ1-Ile resonances is smaller (25 to 75 ms), as expected
from the respective protein sizes (Fig. 2F). Addition of c-di-GMP
strongly increases the 13C T2 times of Rec2 such that
13C T2 times
are effectively doubled, but does not significantly affect those of
δ1-Ile of Rec1 (Fig. 2F and SI Appendix, Fig. S3F). These exper-
iments thus quantitatively confirm that c-di-GMP binding to ShkA
leads to the specific detachment of the Rec2 domain from the
protein core into a dynamic, multiconformational state, which
enables the enzyme to undergo the large motions required for the
phosphoryl transfer reactions.
C-di-GMP Competes with Rec1-Rec2 Linker for Binding to Rec1
Domain. To reveal the molecular mechanism of c-di-GMP–induced
Rec2 domain mobilization, we set out to determine the structure of
the ShkA/c-di-GMP complex. Well-diffracting crystals were
obtained only for the isolated Rec1 domain, but not for full-length
ShkA/c-di-GMP, and the structure was determined to 1.8-Å res-
olution (Fig. 3 A and B and SI Appendix, Table S1). The structure
of the Rec1 domain and of the ligand are very well resolved (SI
Appendix, Fig. S4A). The asymmetric unit contains 2 monomers,
each with a bound monomeric c-di-GMP ligand, which are virtu-
ally identical and superimpose closely with the corresponding
domain in full-length ShkA (SI Appendix, Fig. S4B). In addition, an
intercalated c-di-GMP dimer is observed that mediates a 2-fold
symmetry contact between the 2 Rec1 monomers (SI Appendix,
Fig. S4C) that is most likely a crystal artifact. Indeed, the iso-
thermal titration calorimetry (ITC) data of full-length ShkA are
consistent with a 1:1 stoichiometry (SI Appendix, Fig. S5 A–E).
Monomeric c-di-GMP is bound to the α4-β5-α5 face of Rec1
(Fig. 3 A and B), that is, to the surface that is involved in the
dimerization of canonical Rec domains. The Watson–Crick
edges of both guanine bases form H-bonds with the backbone of
the exposed edge of the β5 edge and the β5-α5 loop. In addition,
Y338 and R344 are forming stacking and cation–π interactions
with the guanyl bases, respectively. S347 is H-bonded to a guanyl
base, and R324 forms an ionic interaction with a c-di-GMP
phosphate. All interacting ShkA residues are highly conserved
in related sequences (Fig. 3C).
In full-length ShkA, the c-di-GMP binding site is occupied by
the Rec1-Rec2 linker (Figs. 1C and 3D). Specifically, residues
shown to be engaged in c-di-GMP binding (Y338, R324, and
R344) are interacting with a conserved DDR motif of the linker
region. Thus, we reasoned that if the DDR segment were to
compete with c-di-GMP binding, its deletion should increase c-di-
GMP affinity. Indeed, affinity measurements by ITC and by a
fluorescence competition assay (FCA) showed that the DHp-CA-
Rec1 construct (residues 1 to 366) had a lower dissociation con-
stant compared to the wild-type or to the DHp-CA-Rec1-DDR
truncation construct (residues 1 to 379) still containing the DDR
segment (Fig. 3E). Why this difference is considerably more pro-
nounced in the fluorescence data is not clear.
Taking together all data on structure and dynamics, we propose
a “ligand-coupled conformational equilibrium” (LCCE) model as
the mechanism underlying c-di-GMP–mediated ShkA activation
(Fig. 4 A and B). In the absence of c-di-GMP, the enzyme is in a
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Fig. 3. C-di-GMP and Rec1-Rec2 linker compete for Rec1 binding. (A and B)
Crystal structure of ShkARec1 in complex with c-di-GMP with interacting residues
shown in full. The Watson–Crick edges of both guanines form H-bonds with
Rec1 main-chain atoms. The bases stack with Y338, Q351 and with R344. The
hydroxyl of S347 is H-bonded to a guanine N7 group. Both Y338 and R324
interact with 1 of the phosphates. See also SI Appendix, Fig. S4. (C) Structure of
Rec1 of full-length ShkA in same orientation as ShkARec1 in A. The comparison
shows that the DDR motif (light-green) is bound to the same site on Rec1 as c-
di-GMP (for a superposition see SI Appendix, Fig. S4B). Note that R324 and R344
of Rec1 are involved both in c-di-GMP and linker binding. (D) C-di-GMP binding
to various ShkA constructs as measured by ITC (Upper) and FCA (Lower). Con-
struct DHp-CA-Rec1 shows a significantly lower dissociation constant compared
to the other variants, which can be attributed to the absence of the competing
DDR segment. Full data are given in SI Appendix, Fig. S5. (E) Sequence logo
encompassing the c-di-GMP binding site of the ShkARec1 domain.
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dynamic equilibrium between a closed, autoinhibited state (Ec)
and an ensemble of open, inhibition-relieved states (Eo) that are
characterized by a liberated Rec2 domain. In the absence of the
ligand, this equilibrium would be populated largely on the Ec side,
in line with the NMR results and the constitutive inactivity of the
enzyme (12). C-di-GMP–mediated ShkA activation would then
proceed by conformational selection (20) of the Eo states with
their unobstructed Rec1 binding site, shifting the equilibrium in a
dose-dependent fashion to these active states.
The regulatory model was tested in vivo by analyzing the
transcriptional activity of the ShkA-ShpA-TacA pathway with a
β-Gal assay (9). In this assay, plasmid-borne variants of shkA
were expressed in a C. crescentus shkA deletion background that
harbors a plasmid-borne translational fusion between the TacA
target gene spmX and lacZ (spmX′-′lacZ). This allowed following
the activity of the ShkA-ShpA-TacA pathway directly by read-
ing out the activity of β-Gal, encoded by lacZ. The assay was
performed in the wild-type and in a c-di-GMP minus strain
[rcdG0 strain (21)]. While in absence of c-di-GMP (rcdG0 strain)
wild-type ShkA showed no activity, introducing D369N or placing
an insertion between the DDR motif and Rec2 (but not between
Rec1 and DDR) rendered ShkA active (Fig. 4C). Thus, the results
fully corroborate the regulatory model, as illustrated in the scheme
(Fig. 4D). Additional support for the model is provided by ana-
lytical ultracentrifugation sedimentation velocity (SV-AUC) ex-
periments (SI Appendix, Fig. S6) that show a decrease in the
sedimentation coefficient upon ligand addition, indicative of a
more open structure. In the following, the LCCE model (Fig. 4 A,
Inset) is scrutinized and its thermodynamic parameters are de-
termined by quantitative functional investigations.
ShkA Autophosphorylation Is c-Di-GMP–Dependent, Reversible, and
Noncooperative. To determine the reaction kinetics of the full-
length ShkA and mutants thereof, we acquired progress curves of
enzyme net phosphorylation (E*) by autoradiography and of
ATP to ADP turnover by on-line ion exchange chromatogra-
phy (oIEC) (SI Appendix, Methods) quantification. First, we de-
termined the kinetics of autophosphorylation separately using
phosphotransfer-deficient variants that had the phospho-acceptor
D430 mutated (ShkAD/A) or the Rec2 domain deleted (construct
DHp-CA-Rec1 or, in short, ShkAΔRec2). As found previously (12)
and consistent with the proposed regulatory model, ShkAΔRec2 is
constitutively active (Fig. 5 A and B), since it lacks the obstructing
Rec2 domain. ShkAΔRec2 attains very quickly (in less than 15 s) a
stable phosphorylation state with or without the ligand; that is, it
proceeds with an autophosphorylation rate constant k1 > 1/(15 s) =
0.07 s−1. For ShkAD/A, the same fast kinetics is observed, but only
in presence of c-di-GMP (Fig. 5 C and D and SI Appendix, Fig.
S7A), which demonstrates that under this condition the mutant is
fully active. In the absence of the ligand, the turnover number is
strongly reduced (k1,-c-di-GMP = 0.012 s
−1) but, within error limits,
phosphorylation is obtained to almost the same degree as for the
activated enzyme. The observations are consistent with the regu-
latory LCCE model (Fig. 4) under the assumption that the samples
had reached equilibrium after the about 15 min before start of
the enzymatic reaction. No attempts were made to determine
the kinetics of the conformational equilibrium or of c-di-GMP
binding, but the ITC spikes induced upon ligand binding didn’t
exhibit unusual broadening (width < 300 s) (SI Appendix, Fig.
S10 A–D). Since the initial reaction velocity is at least 20 times
larger in the presence of c-di-GMP (Fig. 5D), a lower boundary
of 20 can be estimated for the conformational equilibrium
constant K = [Ec]/[Eo].
To obtain more quantitative information about the auto-
phosphorylation reaction, we measured ATP to ADP turnover
by oIEC. Fig. 5 B and D show the ADP progress curves (Fig. 5 B
and D, filled symbols) of the phosphotransfer-deficient ShkA
mutants that turn out to be congruent with the appropriately
scaled phosphorylation curves (Fig. 5 B and D, open symbols).
This indicates stable histidine phosphorylation at the employed
condition as verified by long-term measurements (SI Appendix,
Fig. S8A). Intriguingly, for both mutants, the progress curves
(Fig. 5 B and D) indicate that the phosphotransfer-deficient
mutants do not proceed to full quantitative modification (i.e.,
did not reach the level corresponding to the enzyme concentra-
tion, 10 μM). We reasoned that this may be due to reversibility of
the autophosphorylation reaction, and that only a high ATP
substrate concentration would shift the equilibrium completely to
the product state. Indeed, upon ATP titration, the equilibrium
ADP concentration was increased and reached the expected
value close to the enzyme concentration indicating complete
phosphorylation (Fig. 5E). A simple reversible bi-bi reaction
model (SI Appendix, Methods) reproduced the data well and
yielded an equilibrium constant K1 = k1/k−1 of 0.13 for activated
ShkAD/A. Enzyme titration (SI Appendix, Fig. S8B) confirmed
the result.
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Ec
Eo EoL
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Fig. 4. Mechanistic model of ShkA activation by c-di-GMP induced change of
conformational equilibrium. (A) ShkA is in a dynamic equilibrium between a
closed, autoinhibited conformation as seen in the full-length crystal structure
(Upper) and an ensemble of open, catalytically active conformations with lib-
erated Rec2 domains. An arbitrarily modeled open conformation is shown at
the bottom, full activity probably requires both subunits to be open. C-di-GMP
can bind only to the open conformation, because, in the closed conformation,
the binding site on Rec1 is obstructed by the DDR motif (light-green). (Inset)
Corresponding thermodynamic LCCE model. (B) Schematic representation of
the mechanism shown in A. C-di-GMP (red circle) competes with the DDR motif
(light-green circle) for Rec1 binding resulting in Rec2 liberation allowing ca-
talysis (e.g., autophosphorylation as indicated). (C) In vivo transcription activity
of ShkA variants assayed in a strain harboring a spmX′-′lacZ reporter. Mutation
D369N affects a crucial Rec1-Rec2 linker tethering interaction, mutants li-DDR
and DDR-li have an elongated Rec1-Rec2 linker with the insertion placed N or C
terminal to the DDR motif as indicated in the scheme (D). Strains rcdG0 ΔshkA
(−c-di-GMP) and ΔshkA (+c-di-GMP) expressed the indicated shkA alleles from
plasmid pQF. Note that no inducer (cumate) was present since leaky expression
from the PQ5 promoter was sufficient to complement the ΔshkA phenotype.
Mean values and SDs are shown (n = 3). (D) Schematic representation of wild-
type and mutant ShkA to demonstrate their phenotypes. In absence of c-di-
GMP, mutations D369N and DDR-li both are predicted to liberate the Rec2
domain, which is in line with the data in C.
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C-di-GMP Shifts Conformational ShkA Equilibrium to the Active State.
Full-length ShkA is effectively an ATPase, converting ATP to
ADP via phospho-enzyme intermediates. Progress curves of ATP
turnover acquired under various conditions by oIEC (Fig. 6A and
SI Appendix, Fig. S9C) were fitted with a competitive product
inhibition Michaelis–Menten model (SI Appendix, Fig. S9A) to
derive the enzymatic parameters. The Km and Ki values are both
about 60 μM, a value that agrees well with dissociation constants
of AMPPNP and ADP obtained by FCA, while the ITC mea-
surements agreed less, probably due to the intrinsic limitations of
this method for low-affinity binders (SI Appendix, Fig. S10 A–D).
Interestingly, the FCA measurements clearly showed that c-di-
GMP has no significant effect on mononucleotide affinity (SI
Appendix, Fig. S10 E–H). In the presence of c-di-GMP, ShkA
is rather active (keff = 0.20 s
−1) (Fig. 6A), considering that
the reaction involves 3 individual steps (autophosphorylation,
phosphotransfer, dephosphorylation) and requires several do-
main rearrangements (Discussion). Importantly, low but signifi-
cant activity (keff = 0.0034 s
−1) (Fig. 6A) is observed also in
absence of the activator, which corroborates the LCCE model
and allows an estimation of the conformational equilibrium
constant to K = 58. Assuming the same K, the microscopic
autophosphorylation rate of activated ShkAD/A can be calculated
to k1 = k1,nonact × K = 0.7 s
−1. Regarding wild-type ShkA phos-
phorylation, we confirmed that it gets boosted by c-di-GMP,
but the phosphorylation level is clearly lower than that of the
phosphotransfer-deficient ShkAD/A mutant (SI Appendix, Fig.
S7B), which can be attributed to the dephosphorylation activity
of the former.
To quantitatively describe the activating effect of c-di-GMP,
progress curves were acquired at various c-di-GMP concentrations
(SI Appendix, Fig. S9B) and fitted with the Michaelis–Menten
model. The resulting keff,meas values yielded a sigmoidal activation
profile with Kact = 0.25 μM, as shown in Fig. 6B. This agrees
reasonably well with the (apparent) dissociation constant of c-di-
GMP as determined by ITC (1.5 μM in the presence of AMPPNP)
(SI Appendix, Fig. S5B). The microscopic dissociation constant
in the absence of the competing DDR motif would then be
considerably smaller, namely Kd = Kact/(1 + K) = 4 nM (SI
Appendix, Methods). This value is smaller than that observed
A B
DC
E
Fig. 5. ShkA autophosphorylation is reversible and, in the presence of Rec2, controlled by c-di-GMP. (A and C) ShkAΔRec2 and ShkAD/A phosphorylation after
indicated times of incubation as measured by autoradiography using [γ-32P]-ATP, in the absence and presence of c-di-GMP as indicated. SDS/PAGE gels are
shown below and indicate equal loading. For additional data, see SI Appendix, Fig. S7A. (B and D) Time course of ShkAΔRec2 and ShkAD/A phosphorylation
(hollow symbols) and ADP production (filled symbols), in the absence (blue) and presence (red) of c-di-GMP. Phosphorylation values were calculated from the
band intensities in A and C; ADP concentrations were determined by oIEC. Solid lines represent exponential fittings of the autoradiograph data [for ShkAD/A:
k1,-c-di-GMP = (0.012 ± 0.002)s
−1]. The dashed line indicates the employed enzyme concentration. (A–D) [ShkA variant]: 10 μM, [c-di-GMP]: 25 μM, [ATP]: 200 μM.
(E) Equilibrium concentration of ADP as a function of initial ATP concentration as determined by oIEC. [ShkAD/A]: 20 μM, [c-di-GMP]: 50 μM. The continuous
line is the fit of the simple reversible, noncooperative bi-bi reaction shown on the top to the data with K1 = k1/k−1 = 0.13 and a refined [ShkAD/A] of 23 μM,
(see also SI Appendix, Methods). Reactions with positive or negative cooperativity would yield the dashed curves (calculated with equilibrium constants for
second phosphorylation event of 1.3 and 0.013, respectively) that do not fit the data. (Inset) Representative oIEC chromatogram.
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for the DHp-CA-Rec1 construct by FCA and ITC (80 nM and
300 nM, respectively) (Fig. 3E and SI Appendix, Fig. S5 F–H),
which may be due to residual binding competition by the
truncated Rec1-Rec2 linker.
In summary, the enzymatic characterization shows that, in the
presence of c-di-GMP, ShkA efficiently catalyses ATP turnover
by enabling autophosphorylation and subsequent phosphotransfer
and dephosphorylation. The data fully support the regulatory
LCCE model and thus confirm that the c-di-GMP activation
profile is governed not only by the affinity of the ligand to its
binding site, but also by the free-energy difference between the
conformational states.
Discussion
The structural, dynamic, and functional results presented in this
study consistently show that activation of ShkA proceeds via the
c-di-GMP–mediated liberation of a locked, autoinhibited state
(Fig. 4). Thereby, c-di-GMP competes with the tethering of a
domain linker (Fig. 3 A and D) to unleash the C-terminal domain
allowing the enzyme to step through the catalytic cycle that in-
volves large domain motions (Fig. 7). C-di-GMP interference
with protein–protein interactions as a regulatory mechanism was
also proposed for a YajQ-like transcription factor/coactivator
complex (22), but structural information is missing.
In ShkA, c-di-GMP binds to the edge strand (β5) of the Rec1
β-sheet and the following β5-α5 loop. The Watson–Crick edges
of both guanines form H-bonds with the main chain (Fig. 3B),
reminiscent of the backbone interactions in a β-sheet. The same
kind of interaction occurs in the CckA/c-di-GMP complex, where
1 of the guanines binds to the β-sheet edge of the CA domain
(16). In the accompanying study (12), Y338 was identified as a
c-di-GMP binding residue in a targeted alanine scan. In addition
to Y338A, several other mutants (R324A, I340A, S347A, and
Q351A) showed severely impaired activity in vivo (12). Since all
these residues contribute to c-di-GMP binding (Fig. 3B), this can
be attributed to an impaired activation by the cellular c-di-GMP
pool and suggests that the affinity of wild-type ShkA to c-di-
GMP is finely tuned to its raise in concentration during cell cycle
progression (21).
A mutation of R344, the remaining c-di-GMP binding residue,
showed a wild-type–like phenotype. This may be explained by the
dual role of R344 being involved in c-di-GMP binding as well as
Rec1-Rec2 linker tethering (Fig. 3 A and D), resulting in opposing
effects on activation upon mutation. Although R324 also has such
a dual role, its strong phenotype suggests that this residue con-
tributes more to c-di-GMP binding than to linker tethering. These
observations demonstrate that identification of ligand binding
residues is not straightforward if they are also involved in opposing
activities like protein–protein interactions. However, mutation of
the DDRmotif or inserting a loop between the motif and the Rec2
domain clearly resulted in constitutively active enzyme and, thus,
confirmed the importance of Rec2 tethering for autoinhibition
(Fig. 4C).
The NMR studies on full-length ShkA using specific isotope
labeling of the isoleucine methyl groups provided atomic scale
information of structural and dynamic changes upon ligand
binding (Fig. 2). Binding of c-di-GMP, but not AMPPNP, changed
the dynamics of Rec2 substantially and exclusively, leading to the
conclusion that the mobility of the Rec2 domain is restricted in the
absence of c-di-GMP but is drastically enhanced upon addition of
the ligand such that its relaxation times become comparable to
those of an individual protein of this size. The binding of c-di-
GMP to Rec1 therefore releases Rec2 allosterically.
In order to relate the mechanistic “activation by domain
liberation” model of ShkA with the function of this hybrid kinase,
comprehensive enzymatic data were acquired. The specially de-
veloped oIEC method proved highly valuable as it enabled the
efficient recording of quantitative enzyme progress curves. We
found, using phosphotransfer-deficient mutants, that ShkA auto-
phosphorylation is clearly reversible. Under various titration re-
gimes, the equilibrium concentrations were consistent with a
simple reversible bi-bi reaction with the equilibrium largely on the
side of the reactants (Fig. 5E and SI Appendix, Fig. S8B). Thus, the
degree of phosphorylation depends on the mononucleotide con-
centrations, and a high ADP concentration promotes enzyme
dephosphorylation by back transfer of the phosphoryl group onto
ADP. Reversibility of the HK autophosphorylation reaction was
originally demonstrated for CheA (23) (see also ref. 24 and ref-
erences therein) and KinA (25), and later for NRII (26). Although
largely neglected in the literature, this is probably a general feature
of ATP-driven histidine phosphorylation. It should be tested
whether it can explain the ADP dependence of the kinase reaction
as observed in vitro for HK853 (27) and other HKs (28). The rate
constant of autophosphorylation is with k1 = 0.7 s
−1 at least 30
times faster than measured for other HKs (16, 29). Possibly, some
of these enzymes were partly impaired by truncation or not fully
activated. ATP turnover of full-length ShkA proceeds somewhat
slower, which demonstrates that phosphotransfer and P∼Asp hy-
drolysis are not much slower. To answer whether the latter re-
action is entirely due to the intrinsic lability of the phospho-
aspartate or catalyzed by docking of the Rec2 domain to the
DHp bundle (4, 19) requires further investigations. Although de-
phosphorylation of ShkA has not been investigated in vivo and is
not part of the current model of cell cycle control (30), it may be
controlled by yet unknown factors that, for example, affect the
DHp bundle geometry as in DesK (31). Additionally, the
A B
Fig. 6. C-di-GMP activation profile of wild-type ShkA is consistent with an LCCE model. (A) ADP production in the presence (red symbols) and absence of
25 μM c-di-GMP (blue) as measured by oIEC at room temperature. The reaction was started by addition of 200 μM ATP to 10 μM ShkA in reaction buffer. The
data were fitted (solid line) with a competitive product inhibition Michaelis–Menten model (gray box; shown fully in SI Appendix, Fig. S9A) with Km and Ki
determined by ATP and ADP titration (SI Appendix, Fig. S9C). (B) C-di-GMP activation profile obtained by acquisition of ADP progress curves at various c-di-
GMP concentrations (SI Appendix, Fig. S9B) to yield keff,meas. The data were fitted to the LCCE model shown in the gray box (SI Appendix, Methods).
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counteracting dephosphorylation activity may be relevant for
concentration robust signaling (32).
Evidence has accumulated that HKs form asymmetric dimers
(9) that can catalyze in concert both autophosphorylation and
phosphotransfer and a structural model has been put forward for
CpxA (33). The corresponding model for activated (i.e., c-di-
GMP–complexed) ShkA is shown in Fig. 7 A, Upper, where do-
mains have been placed on the basis of homologous structures
with competent autophosphorylation or phosphotransfer domain
arrangement. Canonical autophosphorylation and phospho-
transfer mechanisms can be anticipated, since the functional
interfaces show no severe clashes or polarity mismatch. Both CA
and Rec2 of subunit A (CAA, Rec2A) (Fig. 7A, bright colors)
would be engaged in concerted catalysis resulting in a net
transfer of a phosphoryl group from CAA bound ATP to the
active aspartate of Rec2A (Fig. 7A, red arrows), while the cor-
responding domain of subunit B (Fig. 7A, tinted colors) would be
in stand-by mode. Subsequently, both domains would dislodge
(Fig. 7A, black arrows), with CAA moving to a near-by parking
position and Rec2A becoming available for down-stream phos-
phoryl transfer (Fig. 7 A, Lower). Concurrently, the catalytic
domains of subunit B would move to catalytically competent
positions, resulting in the same structure as at the beginning,
although 2-fold related and with the roles of the subunits inter-
changed (state 2). After concerted catalysis, equivalent domain
rearrangements would bring back the enzyme to state 1.
In line with the left-handed connectivity of the 2 DHp helices,
the model predicts that autophosphorylation occurs in trans (34).
Due to the almost equal distance between either of the C-termini
of the Rec1 domains and the N terminus of the competently
docked Rec2 domain (about 60 Å), phosphotransfer may occur
in trans or in cis as modeled. In any case, the Rec1-Rec2 linker of
ShkA is long enough (27 residues) to allow simultaneous exe-
cution of autophosphorylation and phosphotransfer. Notably,
also for canonical HHKs (without an intervening domain like
Rec1), this appears possible, since their CA–Rec linkers appear
long enough (23 ± 3 residues for the 23 HHKs in C. crescentus)
to bridge the distance (again 60 Å) (dashed line in Fig. 7A).
A B
C
State 2
State 1
P~AspA
Rec2
CAB
Rec2B
CAB
CAA
ATP
HisB
P~HisAAspA
c-di-GMP
c-di-GMP
Rec1-Rec2
linker
AspB
Rec2A
CAB
Rec2B
CpxA
EnvZ
HK853
ChpT
ShkA
H23
P28
Proi+5
Hisi
WalK
90°
Fig. 7. Proposed domain arrangements during the catalytic cycle of ShkA. (A) During the catalytic cycle, the enzyme adopts 2 asymmetric dimer states that
are structurally identical, but with domain roles interchanged. Subunits are distinguished by color hue (“A”: strong, “B”: weak), the active His and Asp and
ligands are shown in full. State 1 (Upper): CA/ATP and Rec2 of chain A are poised for trans-autophosphorylation and cis-phosphotransfer, respectively. After
concerted execution of the reactions (red arrows), CA/ADP and P∼Rec2 dislodge and CA/ATP, Rec2 of chain B engage with the DHp histidines (black arrows) to
yield state 2 (Lower). The competent DHp/CA and DHp/Rec2 domain arrangements have been modeled based on the structures of CpxA [4BIW (18)] and ChpT/
CtrA(Rec) [4QPJ (37)], respectively. In canonical HHK, CA would be linked directly to Rec2 (dashed line). (B) Part of DHp α1 sequence alignment of selected
pfam HisKA family members. (C) Overlay of DHp α1 helix structures of the HKs of B after superposition of C-terminal parts. The structures with reported
autophosphorylation competent domain arrangement (CpxA, 4BIW; WalK, 5C93; EnvZ, 4KP4) and those in phosphotransfer or dephosphorylation/ar-
rangement (HK853, 3DGE; ChpT, 4QPJ) and ShkA form structural clusters distinguished by the degree of helix kinking. (Right) The kinase competent structures
have the N-terminal part of α1 bent toward the center of the DHp bundle (ShkA in gray).
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Most likely the asymmetry is rooted in the inward kinking of
the N-terminal part of DHp α1 helix upon interaction with the
ATP complexed CA domain (Fig. 7C), which would be sterically
incompatible with an analogous motion of α1 from the other
subunit. This has been discussed and analyzed thoroughly by
Bhate et al. (9) and corroborated by the recent structure and
modeled dynamics of WalK (35). The DHp domain of ShkA
belongs to the major HisKA pfam family (36) that exhibits a
HxxxxP motif (Fig. 7B). Superposition of the C-terminal part of
DHp α1 structures of this family (Fig. 7C) demonstrates kinking
of α1 with a pivot close to the proline and shows that the N-terminal
parts of α1 helices of autophosphorylation competent structures
(CpxA, EnvZ, WalK) are tilted toward the helix bundle axis. A
symmetric structure with both α1 helices tilted inwards is sterically
probably not feasible, which would thus be the basis for the
asymmetry of the functional dimer.
The proposed asymmetric catalysis is not equivalent with half-
of-sites modification and is, therefore, not at odds with our finding
of complete modification at high ATP concentration (Fig. 5E).
Disengagement of the CA domain after the first phosphorylation
event could easily allow the other CA domain to approach the
second histidine for modification (compare states 1 and 2 in Fig.
7A). Intriguingly, however, CpxA shows a hemiphosphorylated
crystal structure in the presence of ATP (33), although the non-
phosphorylated histidine seems perfectly poised to react with CA
bound ATP in the observed canonical kinase competent ar-
rangement. Based on our thermodynamic results on ShkA, we
predict that CpxA behaves similarly, with the equilibrium of the
reversible autophosphorylation reaction being on the side of the
reactants (ATP, His). This would explain why the substrate and
not the product complex was observed, since the products (ADP,
P∼His) would react back and ADP would stay in the active site
assuming strong crystal lattice constraints.
Our analyses provide mechanistic and kinetic insight into how
c-di-GMP competes with a protein–protein interaction to activate
an HHK, and how ADP affects the autophosphorylation reaction.
For a full mechanistic understanding of HHKs, more investiga-
tions are required to decipher the kinetics of the phosphotransfer
and autodephosphorylation steps and to unravel the physiological
advantage of combining HK core and cognate receiver domain on
1 polypeptide.
Materials and Methods
A detailed description of the materials and methods used in this study is
provided in SI Appendix, including the following: Cloning, expression and
protein purification, crystallization, data collection and X-ray structure de-
termination, NMR experiments, ITC and FBC assay, SV-AUC, β-Gal transcrip-
tion assay, radiometric phosphorylation assay, and nucleotide quantification
by oIEC. Also given are the thermodynamic equations for reversible auto-
phosphorylation and the LCCE model used for data fitting.
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